Monographie - Amsacrine - Stabilis 4.0

Ostatnia aktualizacja :
19/11/2024

Lek cytostatyk

Amsacrine

Injekcje

Trwałość roztworów

Trwałość w mieszaninie

Czynnik wpływający na trwałość

Zgodność

Sposób podania

Bibliografia

pdf

Struktura chemiczna

Nazwa handlowa

Nazwa handlowa

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amekrin	Dania, Finlandia, Norwegia, Szwecja
Amsa PD	Kanada
Amsalyo	Francja
Amsidine	Australia, Belgia, Holandia, Włochy
Amsidyl	Niemcy, Szwajcaria

Bibliografia

Injekcje

Bibliografia : Amsacrine

	typ	publikacja
182	Czasopismo	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
253	Czasopismo	Trissel LA, Chandler SW, Folstad JT. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1990 ; 47: 2525-2528.
334	Czasopismo	Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992.
335	Czasopismo	Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406.
492	Czasopismo	Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189.
829	Czasopismo	Cartwright-Shamoon JM, McElnay JC, D'Arcy PF. Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets. Int J Pharm 1988 ; 42: 41-46.
3523	Laboratorium	Ceftriaxone (Rocephin®) - Summary of Product Characteristics. Roche 2018
3576	Laboratorium	Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit Prostrakan 2012
3595	Laboratorium	Aciclovir - Summary of Product Characteristics Hospira 2009
3745	Czasopismo	Kuenhle C, Moore Sodium chloride residue provides potential for drug incompatibiities. Am J Hosp Pharm 1979 ; 36: 881.

Mentions Légales